These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32950067)

  • 1. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
    Schäfer R; Spohn G; Bechtel M; Bojkova D; Baer PC; Kuçi S; Seifried E; Ciesek S; Cinatl J
    Stem Cell Reports; 2021 Mar; 16(3):419-427. PubMed ID: 32950067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
    Avanzini MA; Mura M; Percivalle E; Bastaroli F; Croce S; Valsecchi C; Lenta E; Nykjaer G; Cassaniti I; Bagnarino J; Baldanti F; Zecca M; Comoli P; Gnecchi M
    Stem Cells Transl Med; 2021 Apr; 10(4):636-642. PubMed ID: 33188579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safety consideration of mesenchymal stem cell therapy on COVID-19.
    Cao Y; Wu H; Zhai W; Wang Y; Li M; Li M; Yang L; Tian Y; Song Y; Li J; Wang Y; Ding Q; Zhang L; Cai M; Chang Z
    Stem Cell Res; 2020 Dec; 49():102066. PubMed ID: 33242791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives.
    Karakaş N; Üçüncüoğlu S; Uludağ D; Karaoğlan BS; Shah K; Öztürk G
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes.
    Valeri A; Chiricosta L; Gugliandolo A; Biasin M; Avanzini MA; Calcaterra V; Cappelletti G; Carelli S; Zuccotti GV; Silvestro S; Mazzon E; Pelizzo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous expression of ACE2 and TMPRRS2 in mesenchymal stromal cells.
    Generali M; Kehl D; Wanner D; Okoniewski MJ; Hoerstrup SP; Cinelli P
    J Cell Mol Med; 2022 Jan; 26(1):228-234. PubMed ID: 34821008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.
    Saha S; Chakrabarti S; Singh PK; Poddar J; Satapathi S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):132-143. PubMed ID: 32748331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
    Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
    Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of IFN-γ licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens.
    Bispo ECI; Argañaraz ER; Neves FAR; de Carvalho JL; Saldanha-Araujo F
    Sci Rep; 2024 Oct; 14(1):24235. PubMed ID: 39415027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 Patients.
    Huerga Encabo H; Grey W; Garcia-Albornoz M; Wood H; Ulferts R; Aramburu IV; Kulasekararaj AG; Mufti G; Papayannopoulos V; Beale R; Bonnet D
    Stem Cell Reports; 2021 Mar; 16(3):428-436. PubMed ID: 33581053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
    Calkovska A; Kolomaznik M; Calkovsky V
    Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
    Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
    Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
    Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
    J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
    Xiong J; Bao L; Qi H; Feng Z; Shi Y
    Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.